Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma
Shinsuke Takagawa(Tokyo Medical and Dental University), Kiyoshi Nishioka(Tokyo Medical and Dental University), Gabriella Lakos(Thermo Fisher Scientific (United Kingdom)), John Varga(Michigan Medicine), Yasuji Mori(University of Illinois Chicago), Toshiyuki Yamamoto(Fukushima Medical University)
Cited by 122
Related Papers
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma
|Journal of Investigative Dermatology|1999|437
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227
Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma
|American Journal Of Pathology|2004|213
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
|Arthritis & Rheumatism|2011|211